Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / S&P PHARMAC
-
Number of holders
-
58
-
Total 13F shares, excl. options
-
5,733,102
-
Shares change
-
+1,850,114
-
Total reported value, excl. options
-
$204,044,462
-
Value change
-
+$64,175,230
-
Number of buys
-
22
-
Number of sells
-
-24
-
Price
-
$35.59
Significant Holders of SPDR SERIES TRUST - S&P PHARMAC (XPH) as of Q3 2019
64 filings reported holding XPH - SPDR SERIES TRUST - S&P PHARMAC as of Q3 2019.
SPDR SERIES TRUST - S&P PHARMAC (XPH) has 58 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5,733,102 shares
.
Largest 10 shareholders include CREDIT SUISSE AG/ (1,615,705 shares), JPMORGAN CHASE & CO (1,126,503 shares), BANK OF AMERICA CORP /DE/ (1,020,851 shares), GOLDMAN SACHS GROUP INC (854,473 shares), MORGAN STANLEY (347,313 shares), Wharton Business Group, LLC (102,471 shares), Hochman Cole Investment Advisors, Inc. (66,873 shares), WELLS FARGO & COMPANY/MN (55,679 shares), LPL Financial LLC (50,085 shares), and BARCLAYS PLC (47,400 shares).
This table shows the top 58 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.